Work

• Jul 2025 – presentFounder, SyncOrch — AI-mediated research-collaboration platform (Albuquerque; remote). Governance, evaluation and assurance work product: the v3 instrument and its audit; Tension OS v2.1; Keel; three public GPTs.
• Aug 2014 – Dec 2025Founder, Patient Support Network — healthcare-access and patient-financing venture (New York, Houston, Philadelphia). Successive models (I Help Today, Celyco, PSN) taken to institutional review; PSN-AI prototype in 2025; converged into SyncOrch in July 2025 and closed in December 2025.
• Aug 2014 – May 2016Executive MBA, Yeshiva University, Sy Syms School of Business.
• Sep 2013 – Jun 2014Laboratory Technician, Albert Einstein College of Medicine — preclinical lung- and pancreatic-cancer therapeutics research (autophagy inhibition). Co-author, ACS Medicinal Chemistry Letters (2014): Discovery of Autophagy Inhibitors with Antiproliferative Activity in Lung and Pancreatic Cancer Cells.
• May 2008 – Oct 2012Founder and Operations Manager, Mizonett Companies (Houston; San Juan) — nonprofit fundraising events (a City of Houston Proclamation for the largest) and residents'-association management under three contracts covering about 800 residential units: budgets, collections, vendors, board governance, local regulatory compliance.
• Nov 2007 – Apr 2008Laboratory Technician, Identigene (Houston) — high-volume parentage DNA analysis in an accredited chain-of-custody workflow; an independent development project on a patented ladder technology.
• Aug 2006 – Jul 2007Graduate Research Assistant, UT MD Anderson Cancer Center / UTHealth Graduate School of Biomedical Sciences — doctoral coursework and three research rotations in cancer biology (a STAT3-inhibitor program whose work contributed to later publications).
• Aug 2000 – May 2006BS, Natural Sciences, University of Puerto Rico, Río Piedras. Summer research at Weill Cornell / Memorial Sloan Kettering (2003) and MD Anderson (2004).

The arc

In 2025 the patient-support venture moved to an AI-first model, PSN-AI, with a prototype published but never released to users. It rested on an orchestration concept that exceeded what a single GPT could carry; that concept became SyncOrch, and PSN-AI was kept as a domain proof of concept that was never executed, for non-technical reasons — the industry's rate of technology adoption — and dropped in December 2025. The focus shifted to proving the orchestration concept through laboratory collaboration, which required strong governance. That work produced the v3 evaluation instrument: the current state of the work, and what has been shown to ship.

Institutional review, without names

Each model in the venture line was taken to people who could break it: hospital leadership at an academic medical center in 2014, who validated the problem and questioned sustainability; a bioethics review in 2016 that asked for a follow-up analysis; and in 2025 a Medicare Advantage payer and a health-system executive. None of these were engagements, and none is cited as a reference. They are where the domain judgment was tested.

SyncOrch

An AI-mediated research-collaboration platform in which delegates representing different institutions deliberate across privacy boundaries. It develops on its own clock. The platform itself is at ai.syncorch.com; this site carries only the governance and assurance work it produced.